Zhuang Junlong, Kan Yansheng, Wang Yuwen, Marquis Alessandro, Qiu Xuefeng, Oderda Marco, Huang Haifeng, Gatti Marco, Zhang Fan, Gontero Paolo, Xu Linfeng, Calleris Giorgio, Fu Yao, Zhang Bing, Marra Giancarlo, Guo Hongqian
Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Institute of Urology, Nanjing University, Nanjing, China.
Front Oncol. 2022 Apr 7;12:785684. doi: 10.3389/fonc.2022.785684. eCollection 2022.
This study aimed to evaluate the pathological concordance from combined systematic and MRI-targeted prostate biopsy to final pathology and to verify the effectiveness of a machine learning-based model with targeted biopsy (TB) features in predicting pathological upgrade.
All patients in this study underwent prostate multiparametric MRI (mpMRI), transperineal systematic plus transperineal targeted prostate biopsy under local anesthesia, and robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer (PCa) sequentially from October 2016 to February 2020 in two referral centers. For cores with cancer, grade group (GG) and Gleason score were determined by using the 2014 International Society of Urological Pathology (ISUP) guidelines. Four supervised machine learning methods were employed, including two base classifiers and two ensemble learning-based classifiers. In all classifiers, the training set was 395 of 565 (70%) patients, and the test set was the remaining 170 patients. The prediction performance of each model was evaluated by area under the receiver operating characteristic curve (AUC). The Gini index was used to evaluate the importance of all features and to figure out the most contributed features. A nomogram was established to visually predict the risk of upgrading. Predicted probability was a prevalence rate calculated by a proposed nomogram.
A total of 515 patients were included in our cohort. The combined biopsy had a better concordance of postoperative histopathology than a systematic biopsy (SB) only (48.15% vs. 40.19%, = 0.012). The combined biopsy could significantly reduce the upgrading rate of postoperative pathology, in comparison to SB only (23.30% vs. 39.61%, < 0.0001) or TB only (23.30% vs. 40.19%, < 0.0001). The most common pathological upgrade occurred in ISUP GG1 and GG2, accounting for 53.28% and 20.42%, respectively. All machine learning methods had satisfactory predictive efficacy. The overall accuracy was 0.703, 0.768, 0.794, and 0.761 for logistic regression, random forest, eXtreme Gradient Boosting, and support vector machine, respectively. TB-related features were among the most contributed features of a prediction model for upgrade prediction.
The combined effect of SB plus TB led to a better pathological concordance rate and less upgrading from biopsy to RP. Machine learning models with features of TB to predict PCa GG upgrading have a satisfactory predictive efficacy.
本研究旨在评估系统性与磁共振成像(MRI)靶向联合前列腺活检与最终病理结果之间的病理一致性,并验证基于机器学习且具有靶向活检(TB)特征的模型在预测病理升级方面的有效性。
2016年10月至2020年2月期间,在两个转诊中心,本研究的所有患者均依次接受了前列腺多参数MRI(mpMRI)检查、局部麻醉下经会阴系统性加经会阴靶向前列腺活检,以及机器人辅助腹腔镜前列腺癌根治术(RARP)。对于有癌灶的组织芯,采用2014年国际泌尿病理学会(ISUP)指南确定分级组(GG)和 Gleason评分。采用了四种监督式机器学习方法,包括两种基础分类器和两种基于集成学习的分类器。在所有分类器中,训练集为565例患者中的395例(70%),测试集为其余170例患者。通过受试者操作特征曲线下面积(AUC)评估每个模型的预测性能。基尼指数用于评估所有特征的重要性,并找出贡献最大的特征。建立了列线图以直观预测升级风险。预测概率是通过所提出的列线图计算出的患病率。
我们的队列共纳入515例患者。联合活检术后组织病理学的一致性优于单纯系统性活检(SB)(48.15%对40.19%,P = 0.012)。与单纯SB相比(23.30%对39.61%,P < 0.0001)或单纯TB相比(23.30%对40.19%,P < 0.0001),联合活检可显著降低术后病理升级率。最常见的病理升级发生在ISUP GG1和GG2,分别占53.28%和20.42%。所有机器学习方法均具有令人满意的预测效果。逻辑回归、随机森林、极端梯度提升和支持向量机的总体准确率分别为0.703、0.768、0.794和0.761。TB相关特征是升级预测模型中贡献最大的特征之一。
SB加TB的联合效应导致更好的病理一致性率,且从活检到根治性前列腺切除术(RP)的升级更少。具有TB特征的机器学习模型在预测前列腺癌GG升级方面具有令人满意的预测效果。